Diaceutics (LON:DXRX) Shares Up 2.3% - What's Next?

Shares of Diaceutics PLC (LON:DXRX - Get Free Report) were up 2.3% during trading on Thursday . The company traded as high as GBX 134 ($1.82) and last traded at GBX 132 ($1.79). Approximately 83,595 shares were traded during mid-day trading, a decline of 33% from the average daily volume of 124,969 shares. The stock had previously closed at GBX 129 ($1.75).

Diaceutics Price Performance

The firm has a market cap of £108.87 million, a P/E ratio of -38.26 and a beta of 0.58. The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39. The firm has a 50-day simple moving average of GBX 123.39 and a 200-day simple moving average of GBX 128.78.

Diaceutics (LON:DXRX - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported GBX (2.02) (($0.03)) EPS for the quarter. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%. As a group, analysts forecast that Diaceutics PLC will post 1.0107919 EPS for the current year.

Insider Transactions at Diaceutics

In other news, insider Peter Keeling sold 500,000 shares of the stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of GBX 126 ($1.71), for a total transaction of £630,000 ($853,774.22). Company insiders own 34.30% of the company's stock.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.